The Mycology Laboratory serves as a comprehensive reference facility for all NYSDOH licensed clinical laboratories including: hospitals, academic medical centers, county health departments and commercial laboratories.
The laboratory also administers a NYS Public Health Law, and Federal CLIA ’92 mandated proficiency testing (PT) program for laboratories licensed to test fungal specimens that originated from New York residents.
The laboratory houses a fungal culture collection repository, an outstanding resource for assay development, distribution and sale.
Research and development efforts complement diagnostic and PT programs by focusing on innovations in fungal diagnostics and antifungal testing, mechanisms of fungal pathogenesis, and molecular epidemiology. These activities are carried out in collaboration with scientists at the Wadsworth Center and investigators from around the globe. Excellent opportunities are available for the training of undergraduate, graduate students, post-doctoral fellows and clinical laboratory personnel.
The Wadsworth Center Mycology Laboratory has a long history of excellence in both basic and applied research. The laboratory has made many notable contributions to the field with the most famous being the discoveries of the antifungal drug ‘nystatin’ by Drs. Rachel Fuller Brown and Elizabeth Lee Hazen, and the cryptococcal latex agglutination test by Dr. Morris Gordon.
2017 marks the first year the Association of Public Health Laboratories (APHL), in collaboration with the Centers for Disease Control and Prevention (CDC), has sponsored fellows in the Antimicrobial Resistance Track.
Wadsworth Center tests some of the first cases of an emerging fungal pathogen reported in the United States
In a November 4 press release, the Centers for Disease Control and Prevention cautioned that Candida auris had been detected for the first time in the US in four states: New York, Illinois, Maryland and New...read more